Before this verdict, the Tamil Nadu government had already issued the TET notification for 2025, setting September 8 as the last date for applications. Following the court’s order, the deadline was ...

The tussle between Pattali Makkal Katchi (PMK) founder S. Ramadoss and his estranged son Anbumani Ramadoss reached a crescendo on Thursday (September 11, 2025), when the former announced the expulsion ...

CLEVELAND — Voters across Cleveland cast their ballots Tuesday night in a municipal primary that will help determine key leadership roles that could shape the city's immediate future and send ripple ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

A delegation from the All India Primary Teachers Federation (AITF) recently undertook a critical educational visit to Auroville to address the growing impact of technology, mobile devices, and ...

Tamil Nadu Chief Minister M.K. Stalin’s recent investment tour of Europe has brought major opportunities for the state in renewable energy, education, design, shipping, and manufacturing. One of the ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...

Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...